ARTIMPLANT appoints new CEO (press release)
Kjell Thörnbring has been appointed to the new CEO of Artimplant AB. He has been acting CEO since May 4 and he has at the same time maintained the position of CFO. Kjell Thörnbring has a B.Sc in Business Administration from the Gothenburg University and he has previously had leading positions as CEO and CFO in public Swedish companies.
The following changes have also been implemented in Artimplant´s management group:
Susan Linke has been appointed to Financial Manager. She has been employed by the company since 2007. Susan has earlier been an accountant in the company and she has previously a background as Financial Manager.
Hanna Stenhamre has been appointed to manage the new department Clinical Affairs. Hanna has been employed by Artimplant since 2005 and she has been responsible for preclinical research. Hanna holds a MSc from Chalmers University of Technology and she also holds a PhD in biomaterial science from the Gothenburg University. The department of Clinical Affairs is responsible for clinical studies and clinical documentation and it will have a close cooperation with the marketing and sales department.
”Artimplant has during a...
